サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1245505

爪真菌症の世界市場規模、シェア、産業動向分析レポートタイプ別（遠位爪下、近位爪下、白色表在性、その他）、治療法別（外用、経口、その他）、地域別展望・予測、2022～2028年

Global Onychomycosis Market Size, Share & Industry Trends Analysis Report By Type (Distal Subungual, Proximal Subungual, White Superficial and Others), By Treatment (Topical, Oral and Others), By Regional Outlook and Forecast, 2022 - 2028
出版日: | 発行: KBV Research | ページ情報: 英文 164 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
爪真菌症の世界市場規模、シェア、産業動向分析レポートタイプ別（遠位爪下、近位爪下、白色表在性、その他）、治療法別（外用、経口、その他）、地域別展望・予測、2022～2028年
出版日: 2023年02月28日
発行: KBV Research
ページ情報: 英文 164 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

爪真菌症の世界市場規模は、2028年までに45億米ドルに達すると予測され、予測期間中にCAGR4.8%の市場成長率で上昇すると予想されています。

近位爪下爪真菌症（PSO）の原因菌は、まず近位爪甲の裏側から侵入し、その後、遠位へ感染が広がります。また、エンドニクス爪真菌症（EO）は、爪床感染を伴わない爪甲の真菌の侵入を指します。総ジストロフィー性爪真菌症（TDO）は、他の亜型に続く可能性があり、爪真菌症の最終段階となります。臨床的に非真菌性爪疾患と真菌性爪疾患の両方に類似している続発性爪真菌症（SO）は、非真菌性爪疾患（すなわち乾癬）に二次的に真菌性感染を併発したものを指します。

COVID-19の影響度分析

多くの病院やプライマリケアクリニックがCOVID-19の患者さんに目を向けるようになったため、パンデミックによって診断数が減少し、医薬品をはじめとする爪真菌症治療薬の販売に影響を与えました。また、COVID-19は人々の免疫力にも影響を及ぼし、爪真菌症などの真菌症にかかる確率が高くなりました。また、すでに感染している人には、再発のリスクも倍増しました。したがって、パンデミックは爪真菌症市場に悪影響を及ぼしました。

市場成長要因

パイプラインにある潜在的な候補の研究開発の高まり

爪真菌症は、有病率の上昇に加え、有効な治療法がないことから、より良い薬物療法への需要が高まっています。市販されている外用薬の多くは、爪甲の奥まで届かないため、感染を完全に治すことは不可能です。そのため、多くの企業がこの難題を克服するために、爪の奥深くまで浸透する化合物を見つけようと懸命に努力しています。BB2603（ブルーベリー・セラピューティクス）、Hallux Terbinafine Subungual Gel、MOB-015（Moberg Pharma）など、数多くの企業が新しい治療法の開発に積極的に取り組んでいます。

皮膚糸状菌性爪真菌症の有病率の上昇

爪真菌症の発生率の増加は、市場拡大の主な要因の1つです。爪の真菌症は、指の爪の真菌症よりもはるかに一般的です。皮膚糸状菌が原因となる爪真菌症の有病率の上昇と処方箋数の大幅な増加が、爪真菌症治療薬の需要を後押ししています。世界人口の相当数が爪真菌症に罹患しており、数百万人が爪真菌に悩まされています。爪真菌症の増加のさらなる要因として、糖尿病の発症率が上昇していることが挙げられます。したがって、今後数年間は、これらすべての要因が爪真菌症治療のニーズを促進し、市場に利益をもたらすでしょう。

市場抑制要因

需要弾力性が低く、生命を脅かさない状態であること

また、皮膚糸状菌性爪真菌症は生命を脅かすことがなく、治療効果も低いため、効果のない代替治療法との競争も激しくなっています。例えば、ティーツリーオイルは、爪の感染症の治療に利用されることが増えている代替品です。爪真菌症の治療オプションとして認可されている現在の薬剤は、重大な副作用の可能性があるため、肝臓のスクリーニングとモニタリングが必要です。そのため、治療薬に対する需要の低下は、市場拡大の妨げになる可能性があります。

タイプ別展望

タイプ別に、爪真菌症市場は遠位爪下、白色表在型、近位爪下、その他に分類されます。2021年の爪真菌症市場では、遠位爪下セグメントが最も高い収益シェアを獲得しています。このセグメントの優位性は、需要の高まりとジェネリック普及率の上昇により、FDAがより多くのジェネリック医薬品を認可したことに関連しています。さらに、効果的な薬への需要増に対応するため、より多くの医薬品がパイプラインに存在します。爪真菌症の最も典型的な種類は遠位爪下です。この場合、爪真菌症部分の近縁がぼろぼろになり、黄白色のトゲが爪甲に突出します。

治療の見通し

治療法に基づいて、爪真菌症市場は、経口、局所、その他に分けられます。2021年の爪真菌症市場では、経口薬が大きな収益シェアを記録しました。経口薬は、他の形態の抗真菌薬に比べて治療治癒率が高いだけでなく、治療期間も短いため、このセグメントは成長しています。例えば、塩酸テルビナフィン内服薬は、爪真菌症の治療薬として最も使用されています。さらに、爪真菌症の発症率の上昇に対抗するため、一部のジェネリック医薬品メーカーが内服薬を発売しています。例えば、テオフィリン徐放（ER）錠は、2021年6月に米国FDAによって承認されました。

地域別の展望

地域別に、爪真菌症市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。北米セグメントは、2021年に爪真菌症市場で最大の収益シェアを示しました。同地域における爪真菌症の頻度の増加、および有用な政府政策が成長の要因と考えられます。先進国の中で、北米は一人当たりのヘルスケアコストが最も高い国の一つです。さらに、北米では多くの人が爪真菌症にかかっています。発症率の上昇により、爪真菌症との闘いにおいて効果的な爪真菌症治療へのニーズが高まっています。このため、アメリカの企業は、これらの薬の開発に多額の費用を投じています。

目次

第1章 市場の範囲と調査手法

  • 市場の定義
  • 目的
  • 市場の範囲
  • セグメンテーション
    • 爪真菌症の世界市場、タイプ別
    • 爪真菌症の世界市場、治療法別
    • 爪真菌症の世界市場、地域別
  • 調査手法

第2章 市場の概要

  • イントロダクション
    • 概要
      • 市場の構成とシナリオ
  • 市場に影響を与える主要因
    • 市場促進要因
    • 市場抑制要因

第3章 爪真菌症の世界市場：タイプ別

  • 遠位爪下の世界市場：地域別
  • 近位爪下の世界市場：地域別
  • 白色表在型の世界市場：地域別
  • 地域別、世界のその他市場

第4章 爪真菌症の世界市場：治療法別

  • 外用剤の世界市場：地域別
  • 経口の世界市場：地域別
  • 地域別世界のその他市場

第5章 爪真菌症の世界市場：地域別市場

  • 北米
    • 北米の爪真菌症市場：国別一覧
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州爪真菌症市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州
  • アジア太平洋地域
    • アジア太平洋の爪真菌症の国別市場
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • シンガポール
      • その他アジア太平洋地域
  • LAMEA
    • LAMEAの爪真菌症市場：国別
      • ブラジル
      • アルゼンチン
      • UAE
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • LAMEAの残りの地域

第6章 企業プロファイル

  • Abbott Laboratories
  • Bausch Health Companies, Inc.
  • Bayer AG
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • GlaxoSmithKline PLC（GSK）
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Novartis AG
図表

LIST OF TABLES

  • TABLE 1 Global Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 2 Global Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 3 Global Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 4 Global Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 5 Global Distal Subungual Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Distal Subungual Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Proximal Subungual Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Proximal Subungual Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global White Superficial Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global White Superficial Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 14 Global Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 15 Global Topical Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Topical Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Oral Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Oral Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Onychomycosis Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Onychomycosis Market by Region, 2022 - 2028, USD Million
  • TABLE 23 North America Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 24 North America Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 25 North America Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 26 North America Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 27 North America Distal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 28 North America Distal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 29 North America Proximal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 30 North America Proximal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 31 North America White Superficial Market by Country, 2018 - 2021, USD Million
  • TABLE 32 North America White Superficial Market by Country, 2022 - 2028, USD Million
  • TABLE 33 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 36 North America Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 37 North America Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Onychomycosis Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Onychomycosis Market by Country, 2022 - 2028, USD Million
  • TABLE 45 US Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 46 US Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 47 US Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 48 US Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 49 US Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 50 US Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 51 Canada Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 52 Canada Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 53 Canada Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 54 Canada Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 55 Canada Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 56 Canada Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 57 Mexico Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 58 Mexico Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 59 Mexico Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 60 Mexico Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 61 Mexico Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 62 Mexico Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 63 Rest of North America Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 64 Rest of North America Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 65 Rest of North America Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 66 Rest of North America Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 67 Rest of North America Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 68 Rest of North America Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 69 Europe Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 70 Europe Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 71 Europe Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 72 Europe Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 73 Europe Distal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 74 Europe Distal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 75 Europe Proximal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 76 Europe Proximal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 77 Europe White Superficial Market by Country, 2018 - 2021, USD Million
  • TABLE 78 Europe White Superficial Market by Country, 2022 - 2028, USD Million
  • TABLE 79 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 80 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 81 Europe Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 82 Europe Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 83 Europe Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 84 Europe Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 85 Europe Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 86 Europe Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 87 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 88 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 89 Europe Onychomycosis Market by Country, 2018 - 2021, USD Million
  • TABLE 90 Europe Onychomycosis Market by Country, 2022 - 2028, USD Million
  • TABLE 91 Germany Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 92 Germany Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 93 Germany Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 94 Germany Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 95 Germany Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 96 Germany Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 97 UK Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 98 UK Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 99 UK Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 100 UK Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 101 UK Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 102 UK Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 103 France Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 104 France Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 105 France Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 106 France Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 107 France Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 108 France Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 109 Russia Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 110 Russia Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 111 Russia Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 112 Russia Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 113 Russia Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 114 Russia Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 115 Spain Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 116 Spain Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 117 Spain Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 118 Spain Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 119 Spain Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 120 Spain Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 121 Italy Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 122 Italy Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 123 Italy Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 124 Italy Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 125 Italy Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 126 Italy Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 127 Rest of Europe Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 128 Rest of Europe Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 129 Rest of Europe Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 130 Rest of Europe Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 131 Rest of Europe Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 132 Rest of Europe Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 133 Asia Pacific Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 134 Asia Pacific Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 135 Asia Pacific Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 136 Asia Pacific Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 137 Asia Pacific Distal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 138 Asia Pacific Distal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 139 Asia Pacific Proximal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 140 Asia Pacific Proximal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 141 Asia Pacific White Superficial Market by Country, 2018 - 2021, USD Million
  • TABLE 142 Asia Pacific White Superficial Market by Country, 2022 - 2028, USD Million
  • TABLE 143 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 144 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 145 Asia Pacific Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 146 Asia Pacific Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 147 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 148 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 149 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 150 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 151 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 152 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 153 Asia Pacific Onychomycosis Market by Country, 2018 - 2021, USD Million
  • TABLE 154 Asia Pacific Onychomycosis Market by Country, 2022 - 2028, USD Million
  • TABLE 155 China Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 156 China Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 157 China Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 158 China Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 159 China Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 160 China Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 161 Japan Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 162 Japan Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 163 Japan Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 164 Japan Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 165 Japan Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 166 Japan Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 167 India Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 168 India Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 169 India Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 170 India Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 171 India Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 172 India Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 173 Australia Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 174 Australia Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 175 Australia Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 176 Australia Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 177 Australia Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 178 Australia Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 179 South Korea Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 180 South Korea Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 181 South Korea Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 182 South Korea Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 183 South Korea Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 184 South Korea Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 185 Singapore Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 186 Singapore Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 187 Singapore Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 188 Singapore Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 189 Singapore Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 190 Singapore Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 191 Rest of Asia Pacific Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 192 Rest of Asia Pacific Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 193 Rest of Asia Pacific Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 194 Rest of Asia Pacific Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 195 Rest of Asia Pacific Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 196 Rest of Asia Pacific Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 197 LAMEA Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 198 LAMEA Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 199 LAMEA Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 200 LAMEA Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 201 LAMEA Distal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 202 LAMEA Distal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 203 LAMEA Proximal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 204 LAMEA Proximal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 205 LAMEA White Superficial Market by Country, 2018 - 2021, USD Million
  • TABLE 206 LAMEA White Superficial Market by Country, 2022 - 2028, USD Million
  • TABLE 207 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 208 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 209 LAMEA Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 210 LAMEA Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 211 LAMEA Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 212 LAMEA Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 213 LAMEA Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 214 LAMEA Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 215 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 216 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 217 LAMEA Onychomycosis Market by Country, 2018 - 2021, USD Million
  • TABLE 218 LAMEA Onychomycosis Market by Country, 2022 - 2028, USD Million
  • TABLE 219 Brazil Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 220 Brazil Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 221 Brazil Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 222 Brazil Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 223 Brazil Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 224 Brazil Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 225 Argentina Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 226 Argentina Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 227 Argentina Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 228 Argentina Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 229 Argentina Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 230 Argentina Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 231 UAE Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 232 UAE Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 233 UAE Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 234 UAE Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 235 UAE Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 236 UAE Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 237 Saudi Arabia Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 238 Saudi Arabia Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 239 Saudi Arabia Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 240 Saudi Arabia Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 241 Saudi Arabia Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 242 Saudi Arabia Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 243 South Africa Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 244 South Africa Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 245 South Africa Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 246 South Africa Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 247 South Africa Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 248 South Africa Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 249 Nigeria Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 250 Nigeria Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 251 Nigeria Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 252 Nigeria Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 253 Nigeria Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 254 Nigeria Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 255 Rest of LAMEA Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 256 Rest of LAMEA Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 257 Rest of LAMEA Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 258 Rest of LAMEA Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 259 Rest of LAMEA Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 260 Rest of LAMEA Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 261 Key Information - Abbott Laboratories
  • TABLE 262 key information - Bausch Health Companies, Inc.
  • TABLE 263 Key Information - Bayer AG
  • TABLE 264 Key Information - Cipla Limited
  • TABLE 265 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 266 Key Information - GlaxoSmithKline PLC (GSK)
  • TABLE 267 Key Information - Pfizer, Inc.
  • TABLE 268 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 269 KEY INFORMATION - Merck & Co., Inc.
  • TABLE 270 Key Information - Novartis AG

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Onychomycosis Market Share by Type, 2021
  • FIG 3 Global Onychomycosis Market Share by Type, 2028
  • FIG 4 Global Onychomycosis Market by Type, 2018 - 2028, USD Million
  • FIG 5 Global Onychomycosis Market Share by Treatment, 2021
  • FIG 6 Global Onychomycosis Market Share by Treatment, 2028
  • FIG 7 Global Onychomycosis Market by Treatment, 2018 - 2028, USD Million
  • FIG 8 Global Onychomycosis Market Share by Region, 2021
  • FIG 9 Global Onychomycosis Market Share by Region, 2028
  • FIG 10 Global Onychomycosis Market by Region, 2018 - 2028, USD Million
  • FIG 11 Swot analysis: Abbott laboratories
目次

The Global Onychomycosis Market size is expected to reach $4.5 billion by 2028, rising at a market growth of 4.8% CAGR during the forecast period.

A fungal infection of nails called onychomycosis results in thickening and discoloration of the nail plate. In general, the word onychomycosis covers infections caused by yeasts, saprophytic molds, and dermatophytes in addition to dermatophytes. Though fingernails, as well as toenails, can get infected, toenail onychomycosis is more common. Recent studies have shown that mixed infections and infections brought on by non-dermatophyte molds (NDMs) are more common, particularly in warmer climates.

The dermatophyte-induced onychomycosis condition is known as tinea unguium. Subtypes of onychomycosis are categorized according to the invasion pattern. The most prevalent form of onychomycosis, known as distal subungual onychomycosis (DSO), happens when the fungus colonizes the distal portion of the nail plate. Fungi infiltrate the nail plate's outermost layers in superficial white onychomycosis (SWO).

The organism that causes proximal subungual onychomycosis (PSO) first invades from the underside of the proximal nail fold, then the infection subsequently spreads distally. Additionally, Endonyx onychomycosis (EO) refers to the nail plate's fungal invasion that does not involve nail bed infection. Total dystrophic onychomycosis (TDO), which may follow any other subtypes, is the final stage of onychomycosis. Clinically resembling both the non-fungal and fungal nail disorders, secondary onychomycosis (SO) refers to the non-fungal nail condition (that is, psoriasis) along with a secondary fungal infection.

COVID-19 Impact Analysis

As many hospital institutions and primary care clinics switched their attention to COVID-19 patients, the pandemic led to a decline in diagnoses and had an impact on the sales of medications and other onychomycosis treatment options. In addition, COVID-19 also affected the immunity of people, which increased the chances for acquiring fungal diseases like onychomycosis. The risk of recurrence also multiplied for people who already had the infection. Therefore, the pandemic had an adverse impact on the onychomycosis market.

Market Growth Factors

Rising research and development of potential candidates in the pipeline

The rising prevalence of onychomycosis coupled with a lack of viable treatments have increased the demand for better medication. Many of the topical medications on the market cannot reach the depths of the nail bed, making it impossible to entirely heal the infection. As a result, many businesses are trying hard to find compounds that penetrate the nails deeper to overcome this difficulty. Numerous businesses are actively developing new treatments, including BB2603 (Blueberry Therapeutics), Hallux Terbinafine Subungual Gel, and MOB-015 (Moberg Pharma).

Growing prevalence of dermatophytic onychomycosis

Onychomycosis' increasing incidence is one of the major factors propelling the market's expansion. Infection of the toenail onychomycosis is far more common than that of the fingernails. The rising prevalence of dermatophyte-caused nail fungal infections and a large rise in the number of prescriptions are propelling the demand for onychomycosis treatment. A significant number of the world's population has onychomycosis, with millions suffering from nail fungus. A further factor contributing to the rise in dermatophytic infection is the rising incidence of diabetes. Hence, in the coming years, all these factors will expedite the need for onychomycosis treatment, which would benefit the market.

Market Restraining Factors

Low demand elasticity and non-life-threatening condition

The non-life-threatening characteristics of dermatophytic onychomycosis and the treatment's poor efficacy have also led to intense competition from ineffective alternative treatment methods. For instance, tea tree oil is a substitute product that is increasingly utilized to treat nail infections. Since the current medications licensed for the treatment option of onychomycosis have the potential for significant side effects, liver screening and monitoring are necessary. Therefore, the lower demand for the treatment have the potential to hamper the expansion of the market.

Type Outlook

Based on type, the onychomycosis market is categorized into distal subungual, white superficial, proximal subungual, and others. The distal subungual segment garnered the highest revenue share in the onychomycosis market in 2021. The segment's dominance is linked to the FDA's clearance of more generic drugs due to rising demand and rising generic prevalence. Additionally, there are more pharmaceuticals in the pipeline to address the increased demand for effective medications. The most typical kind of onychomycosis is distal subungual. In this, the onycholytic area's proximal edge is ragged, and yellow-white spikes protrude into the nail plate.

Treatment Outlook

On the basis of treatment, the onychomycosis market is divided into oral, topical, and others. The oral segment recorded a significant revenue share in the onychomycosis market in 2021. The segment is growing since oral medications have greater treatment cure rates as well as shorter treatment periods than other forms of antifungals. For example, terbinafine hydrochloride oral medication is the most used treatment for onychomycosis. Additionally, to combat the rising incidence of onychomycosis, some generic drug makers are introducing oral medicines. Theophylline extended-release (ER) tablets, for example, were approved by the U.S. FDA in June 2021.

Regional Outlook

Based on region, the onychomycosis market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the maximum revenue share in the onychomycosis market in 2021. Onychomycosis's increased frequency in the region as well as helpful government policies can be attributed to the growth. Among the developed nations, North America has one of the highest per capita healthcare costs. Additionally, many people in North America have onychomycosis. The rising incidence rate is increasing the need for effective onychomycosis treatments in the fight against the disease. Due to this, American businesses have made large expenditures in the creation of these medications.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Abbott Laboratories, Bausch Health Companies, Inc., Bayer AG, Cipla Limited, Merck & Co., Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., and GlaxoSmithKline PLC.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Distal Subungual
  • Proximal Subungual
  • White Superficial
  • Others

By Treatment

  • Topical
  • Oral
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Singapore
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Pfizer, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Abbott Laboratories
  • Bausch Health Companies, Inc.
  • Bayer AG
  • Cipla Limited
  • Merck & Co., Inc.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • GlaxoSmithKline PLC

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Onychomycosis Market, by Type
    • 1.4.2 Global Onychomycosis Market, by Treatment
    • 1.4.3 Global Onychomycosis Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Onychomycosis Market by Type

  • 3.1 Global Distal Subungual Market by Region
  • 3.2 Global Proximal Subungual Market by Region
  • 3.3 Global White Superficial Market by Region
  • 3.4 Global Others Market by Region

Chapter 4. Global Onychomycosis Market by Treatment

  • 4.1 Global Topical Market by Region
  • 4.2 Global Oral Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Onychomycosis Market by Region

  • 5.1 North America Onychomycosis Market
    • 5.1.1 North America Onychomycosis Market by Type
      • 5.1.1.1 North America Distal Subungual Market by Country
      • 5.1.1.2 North America Proximal Subungual Market by Country
      • 5.1.1.3 North America White Superficial Market by Country
      • 5.1.1.4 North America Others Market by Country
    • 5.1.2 North America Onychomycosis Market by Treatment
      • 5.1.2.1 North America Topical Market by Country
      • 5.1.2.2 North America Oral Market by Country
      • 5.1.2.3 North America Others Market by Country
    • 5.1.3 North America Onychomycosis Market by Country
      • 5.1.3.1 US Onychomycosis Market
        • 5.1.3.1.1 US Onychomycosis Market by Type
        • 5.1.3.1.2 US Onychomycosis Market by Treatment
      • 5.1.3.2 Canada Onychomycosis Market
        • 5.1.3.2.1 Canada Onychomycosis Market by Type
        • 5.1.3.2.2 Canada Onychomycosis Market by Treatment
      • 5.1.3.3 Mexico Onychomycosis Market
        • 5.1.3.3.1 Mexico Onychomycosis Market by Type
        • 5.1.3.3.2 Mexico Onychomycosis Market by Treatment
      • 5.1.3.4 Rest of North America Onychomycosis Market
        • 5.1.3.4.1 Rest of North America Onychomycosis Market by Type
        • 5.1.3.4.2 Rest of North America Onychomycosis Market by Treatment
  • 5.2 Europe Onychomycosis Market
    • 5.2.1 Europe Onychomycosis Market by Type
      • 5.2.1.1 Europe Distal Subungual Market by Country
      • 5.2.1.2 Europe Proximal Subungual Market by Country
      • 5.2.1.3 Europe White Superficial Market by Country
      • 5.2.1.4 Europe Others Market by Country
    • 5.2.2 Europe Onychomycosis Market by Treatment
      • 5.2.2.1 Europe Topical Market by Country
      • 5.2.2.2 Europe Oral Market by Country
      • 5.2.2.3 Europe Others Market by Country
    • 5.2.3 Europe Onychomycosis Market by Country
      • 5.2.3.1 Germany Onychomycosis Market
        • 5.2.3.1.1 Germany Onychomycosis Market by Type
        • 5.2.3.1.2 Germany Onychomycosis Market by Treatment
      • 5.2.3.2 UK Onychomycosis Market
        • 5.2.3.2.1 UK Onychomycosis Market by Type
        • 5.2.3.2.2 UK Onychomycosis Market by Treatment
      • 5.2.3.3 France Onychomycosis Market
        • 5.2.3.3.1 France Onychomycosis Market by Type
        • 5.2.3.3.2 France Onychomycosis Market by Treatment
      • 5.2.3.4 Russia Onychomycosis Market
        • 5.2.3.4.1 Russia Onychomycosis Market by Type
        • 5.2.3.4.2 Russia Onychomycosis Market by Treatment
      • 5.2.3.5 Spain Onychomycosis Market
        • 5.2.3.5.1 Spain Onychomycosis Market by Type
        • 5.2.3.5.2 Spain Onychomycosis Market by Treatment
      • 5.2.3.6 Italy Onychomycosis Market
        • 5.2.3.6.1 Italy Onychomycosis Market by Type
        • 5.2.3.6.2 Italy Onychomycosis Market by Treatment
      • 5.2.3.7 Rest of Europe Onychomycosis Market
        • 5.2.3.7.1 Rest of Europe Onychomycosis Market by Type
        • 5.2.3.7.2 Rest of Europe Onychomycosis Market by Treatment
  • 5.3 Asia Pacific Onychomycosis Market
    • 5.3.1 Asia Pacific Onychomycosis Market by Type
      • 5.3.1.1 Asia Pacific Distal Subungual Market by Country
      • 5.3.1.2 Asia Pacific Proximal Subungual Market by Country
      • 5.3.1.3 Asia Pacific White Superficial Market by Country
      • 5.3.1.4 Asia Pacific Others Market by Country
    • 5.3.2 Asia Pacific Onychomycosis Market by Treatment
      • 5.3.2.1 Asia Pacific Topical Market by Country
      • 5.3.2.2 Asia Pacific Oral Market by Country
      • 5.3.2.3 Asia Pacific Others Market by Country
    • 5.3.3 Asia Pacific Onychomycosis Market by Country
      • 5.3.3.1 China Onychomycosis Market
        • 5.3.3.1.1 China Onychomycosis Market by Type
        • 5.3.3.1.2 China Onychomycosis Market by Treatment
      • 5.3.3.2 Japan Onychomycosis Market
        • 5.3.3.2.1 Japan Onychomycosis Market by Type
        • 5.3.3.2.2 Japan Onychomycosis Market by Treatment
      • 5.3.3.3 India Onychomycosis Market
        • 5.3.3.3.1 India Onychomycosis Market by Type
        • 5.3.3.3.2 India Onychomycosis Market by Treatment
      • 5.3.3.4 Australia Onychomycosis Market
        • 5.3.3.4.1 Australia Onychomycosis Market by Type
        • 5.3.3.4.2 Australia Onychomycosis Market by Treatment
      • 5.3.3.5 South Korea Onychomycosis Market
        • 5.3.3.5.1 South Korea Onychomycosis Market by Type
        • 5.3.3.5.2 South Korea Onychomycosis Market by Treatment
      • 5.3.3.6 Singapore Onychomycosis Market
        • 5.3.3.6.1 Singapore Onychomycosis Market by Type
        • 5.3.3.6.2 Singapore Onychomycosis Market by Treatment
      • 5.3.3.7 Rest of Asia Pacific Onychomycosis Market
        • 5.3.3.7.1 Rest of Asia Pacific Onychomycosis Market by Type
        • 5.3.3.7.2 Rest of Asia Pacific Onychomycosis Market by Treatment
  • 5.4 LAMEA Onychomycosis Market
    • 5.4.1 LAMEA Onychomycosis Market by Type
      • 5.4.1.1 LAMEA Distal Subungual Market by Country
      • 5.4.1.2 LAMEA Proximal Subungual Market by Country
      • 5.4.1.3 LAMEA White Superficial Market by Country
      • 5.4.1.4 LAMEA Others Market by Country
    • 5.4.2 LAMEA Onychomycosis Market by Treatment
      • 5.4.2.1 LAMEA Topical Market by Country
      • 5.4.2.2 LAMEA Oral Market by Country
      • 5.4.2.3 LAMEA Others Market by Country
    • 5.4.3 LAMEA Onychomycosis Market by Country
      • 5.4.3.1 Brazil Onychomycosis Market
        • 5.4.3.1.1 Brazil Onychomycosis Market by Type
        • 5.4.3.1.2 Brazil Onychomycosis Market by Treatment
      • 5.4.3.2 Argentina Onychomycosis Market
        • 5.4.3.2.1 Argentina Onychomycosis Market by Type
        • 5.4.3.2.2 Argentina Onychomycosis Market by Treatment
      • 5.4.3.3 UAE Onychomycosis Market
        • 5.4.3.3.1 UAE Onychomycosis Market by Type
        • 5.4.3.3.2 UAE Onychomycosis Market by Treatment
      • 5.4.3.4 Saudi Arabia Onychomycosis Market
        • 5.4.3.4.1 Saudi Arabia Onychomycosis Market by Type
        • 5.4.3.4.2 Saudi Arabia Onychomycosis Market by Treatment
      • 5.4.3.5 South Africa Onychomycosis Market
        • 5.4.3.5.1 South Africa Onychomycosis Market by Type
        • 5.4.3.5.2 South Africa Onychomycosis Market by Treatment
      • 5.4.3.6 Nigeria Onychomycosis Market
        • 5.4.3.6.1 Nigeria Onychomycosis Market by Type
        • 5.4.3.6.2 Nigeria Onychomycosis Market by Treatment
      • 5.4.3.7 Rest of LAMEA Onychomycosis Market
        • 5.4.3.7.1 Rest of LAMEA Onychomycosis Market by Type
        • 5.4.3.7.2 Rest of LAMEA Onychomycosis Market by Treatment

Chapter 6. Company Profiles

  • 6.1 Abbott Laboratories
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental and Regional Analysis
    • 6.1.4 Research & Development Expense
    • 6.1.5 SWOT Analysis
  • 6.2 Bausch Health Companies, Inc.
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Segmental and Regional Analysis
    • 6.2.4 Research & Development Expense
    • 6.2.5 Recent strategies and developments:
      • 6.2.5.1 Trials and Approvals:
  • 6.3 Bayer AG
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Segmental and Regional Analysis
    • 6.3.4 Research & Development Expense
    • 6.3.5 Recent strategies and developments:
      • 6.3.5.1 Product Launches and Expansions:
  • 6.4 Cipla Limited
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Regional Analysis
    • 6.4.4 Research & Development Expense
    • 6.4.5 Recent strategies and developments:
      • 6.4.5.1 Product Launches and Product Expansions:
  • 6.5 Sun Pharmaceutical Industries Ltd.
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Regional & Segmental Analysis
    • 6.5.4 Research & Development Expenses
    • 6.5.5 Recent strategies and developments:
      • 6.5.5.1 Acquisition and Mergers:
  • 6.6 GlaxoSmithKline PLC (GSK)
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Segmental and Regional Analysis
    • 6.6.4 Research & Development Expense
    • 6.6.5 Recent strategies and developments:
      • 6.6.5.1 Partnerships, Collaborations, and Agreements:
  • 6.7 Pfizer, Inc.
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Regional & Segmental Analysis
    • 6.7.4 Research & Development Expense
  • 6.8 Teva Pharmaceutical Industries Ltd.
    • 6.8.1 Company Overview
    • 6.8.2 Financial Analysis
    • 6.8.3 Regional Analysis
    • 6.8.4 Research & Development Expenses
  • 6.9 Merck & Co., Inc.
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Segmental and Regional Analysis
    • 6.9.4 Research & Development Expenses
  • 6.10. Novartis AG
    • 6.10.1 Company Overview
    • 6.10.2 Financial Analysis
    • 6.10.3 Segmental and Regional Analysis
    • 6.10.4 Research & Development Expense